nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB3—type 2 diabetes mellitus	0.604	1	CbGaD
Alprenolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0989	0.326	CbGbCtD
Alprenolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0792	0.261	CbGbCtD
Alprenolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0367	0.121	CbGbCtD
Alprenolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0338	0.112	CbGbCtD
Alprenolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0278	0.0917	CbGbCtD
Alprenolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0266	0.0879	CbGbCtD
Alprenolol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00738	0.739	CbGeAlD
Alprenolol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000996	0.0998	CbGeAlD
Alprenolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000882	0.392	CrCbGaD
Alprenolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000481	0.214	CrCbGaD
Alprenolol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000462	0.0463	CbGeAlD
Alprenolol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000407	0.0408	CbGeAlD
Alprenolol—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000396	0.0397	CbGeAlD
Alprenolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000388	0.172	CrCbGaD
Alprenolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000248	0.11	CrCbGaD
Alprenolol—CYP2D6—kidney—type 2 diabetes mellitus	0.00021	0.0211	CbGeAlD
Alprenolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000151	0.0672	CrCbGaD
Alprenolol—CYP2D6—liver—type 2 diabetes mellitus	0.000133	0.0133	CbGeAlD
Alprenolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.0001	0.0445	CrCbGaD
Alprenolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.4e-05	0.000175	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.4e-05	0.000174	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.4e-05	0.000174	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.38e-05	0.000172	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.38e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.38e-05	0.000171	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.37e-05	0.000171	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.37e-05	0.000171	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.37e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.37e-05	0.000171	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.35e-05	0.000169	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000168	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.33e-05	0.000166	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.33e-05	0.000165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.32e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.31e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.31e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.3e-05	0.000162	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.3e-05	0.000162	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.3e-05	0.000161	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.29e-05	0.000161	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.29e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.29e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.28e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.28e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.28e-05	0.000159	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.27e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.26e-05	0.000157	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.26e-05	0.000157	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.25e-05	0.000156	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.25e-05	0.000156	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.24e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.24e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.24e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.24e-05	0.000155	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—type 2 diabetes mellitus	1.24e-05	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.23e-05	0.000154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.23e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.23e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.22e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.2e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.2e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.2e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.2e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.2e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.19e-05	0.000149	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.19e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.18e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000147	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.17e-05	0.000146	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.15e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.14e-05	0.000142	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.14e-05	0.000142	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.13e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.12e-05	0.000139	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.11e-05	0.000139	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.11e-05	0.000139	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.11e-05	0.000138	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.11e-05	0.000138	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.1e-05	0.000138	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.1e-05	0.000138	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.09e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.08e-05	0.000135	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.08e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.08e-05	0.000134	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.07e-05	0.000134	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.07e-05	0.000133	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.07e-05	0.000133	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.07e-05	0.000133	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.06e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.06e-05	0.000132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.06e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.05e-05	0.000131	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.05e-05	0.000131	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.05e-05	0.00013	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.04e-05	0.000129	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-05	0.000129	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.03e-05	0.000128	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.03e-05	0.000128	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.03e-05	0.000128	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.02e-05	0.000128	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.01e-05	0.000126	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.01e-05	0.000126	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.01e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.01e-05	0.000125	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.01e-05	0.000125	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	9.94e-06	0.000124	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	9.87e-06	0.000123	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	9.87e-06	0.000123	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	9.87e-06	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.85e-06	0.000123	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.84e-06	0.000123	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	9.81e-06	0.000122	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.65e-06	0.00012	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	9.64e-06	0.00012	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.63e-06	0.00012	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	9.53e-06	0.000119	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.48e-06	0.000118	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.44e-06	0.000118	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.32e-06	0.000116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.27e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	9.26e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.24e-06	0.000115	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.23e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.18e-06	0.000114	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.06e-06	0.000113	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.06e-06	0.000113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.86e-06	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	8.86e-06	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	8.86e-06	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	8.86e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.83e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.81e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.8e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.73e-06	0.000109	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	8.69e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.65e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.64e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.64e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.62e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.62e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.62e-06	0.000107	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	8.61e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.61e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.52e-06	0.000106	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.47e-06	0.000105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.46e-06	0.000105	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.45e-06	0.000105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.43e-06	0.000105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.43e-06	0.000105	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	8.43e-06	0.000105	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.43e-06	0.000105	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	8.42e-06	0.000105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.34e-06	0.000104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.27e-06	0.000103	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	8.25e-06	0.000103	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	8.25e-06	0.000103	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.15e-06	0.000102	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.13e-06	0.000101	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.1e-06	0.000101	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	8.05e-06	0.0001	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.01e-06	9.98e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.01e-06	9.98e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.95e-06	9.91e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.84e-06	9.76e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.81e-06	9.73e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.78e-06	9.69e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.69e-06	9.58e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	7.68e-06	9.56e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.68e-06	9.56e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.52e-06	9.37e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	7.36e-06	9.17e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.36e-06	9.16e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.25e-06	9.03e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.2e-06	8.97e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.19e-06	8.96e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.12e-06	8.87e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.12e-06	8.87e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.09e-06	8.83e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.09e-06	8.83e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.05e-06	8.79e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	7.04e-06	8.77e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.97e-06	8.68e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.96e-06	8.67e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.93e-06	8.64e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.93e-06	8.63e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.81e-06	8.49e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.81e-06	8.48e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.78e-06	8.45e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.76e-06	8.43e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.62e-06	8.24e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.62e-06	8.24e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.62e-06	8.24e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.59e-06	8.21e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.5e-06	8.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.47e-06	8.06e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.46e-06	8.04e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.46e-06	8.04e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.32e-06	7.87e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.32e-06	7.87e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.31e-06	7.86e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.18e-06	7.69e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.18e-06	7.69e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.14e-06	7.65e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.08e-06	7.57e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.03e-06	7.51e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.95e-06	7.41e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.9e-06	7.35e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.88e-06	7.32e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.81e-06	7.24e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.72e-06	7.13e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.65e-06	7.04e-05	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.53e-06	6.89e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.48e-06	6.83e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.45e-06	6.79e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.42e-06	6.76e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.42e-06	6.75e-05	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.41e-06	6.74e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.36e-06	6.68e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.33e-06	6.64e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.32e-06	6.63e-05	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.29e-06	6.59e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.24e-06	6.53e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.21e-06	6.49e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.18e-06	6.45e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.15e-06	6.42e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.13e-06	6.39e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.07e-06	6.31e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.07e-06	6.31e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.05e-06	6.29e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.03e-06	6.26e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.01e-06	6.25e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5e-06	6.23e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.99e-06	6.22e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.96e-06	6.17e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.92e-06	6.12e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.9e-06	6.11e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.81e-06	5.99e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.78e-06	5.95e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.67e-06	5.82e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.65e-06	5.8e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.57e-06	5.69e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.55e-06	5.67e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.45e-06	5.54e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.4e-06	5.48e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.31e-06	5.37e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.27e-06	5.32e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.19e-06	5.22e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.18e-06	5.2e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.1e-06	5.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.08e-06	5.09e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.01e-06	4.99e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.96e-06	4.93e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.78e-06	4.71e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.78e-06	4.71e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.46e-06	4.31e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.22e-06	4.01e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.15e-06	3.92e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.08e-06	3.83e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.97e-06	3.7e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.9e-06	3.62e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.84e-06	3.54e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	2.17e-05	CbGpPWpGaD
